H. Nieuwenhuis

发表

Large platelets continue to circulate in an activated state after myocardial infarction

D. Tschoepe, J. Esser, B. Strauer, 1994, European journal of clinical investigation.

Ultrastructural expression of P-selectin on surface activated platelets.

J. White, G. Escolar, G. Rao, 1996, Platelets.

Low-Density Lipoprotein Enhances Platelet Secretion Via Integrin-αIIbβ3–Mediated Signaling

M. Huigsloot, J. Akkerman, C. Hackeng, 1999 .

Low-Density Lipoprotein Enhances Platelet Secretion Via Integrin- aIIb b3–Mediated Signaling

M. Huigsloot, J. Akkerman, M. W. Pladet, 1999 .

Circulating activated platelets in myeloproliferative disorders.

J. Esser, A. Wehmeier, W. Schneider, 1991, Thrombosis research.

X-linked sideroblastic anaemia due to ALAS₂ mutations in the Netherlands: a disease in disguise.

D. Swinkels, M. Coenen, R. Raymakers, 2014, The Netherlands journal of medicine.

Influence of Factor Xllla Activity on Human Whole Blood Clot Lysis In Vitro

C. Kluft, F. Haverkate, J. Koopman, 1987, Thrombosis and Haemostasis.

a 2-Antiplasmin Enschede : Dysfunctional a 2-Antiplasmin Molecule Associated with an Autosomal Recessive Hemorrhagic Disorder

J., G. Dooijewaard, C. Kluft, 2013 .

Autosomal Recessive Hemorrhagic Disorder

G. Dooijewaard, C. Kluft, D. Rijken, 2022 .

alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.

G. Dooijewaard, C. Kluft, D. Rijken, 1987, Journal of Clinical Investigation.

Elastase Mediated Fibrinolysis in Acute Promyelocytic Leukemia

R. Fijnheer, E. Oudijk, H. Nieuwenhuis, 2000, Thrombosis and Haemostasis.

Reduced activity of TAFI (thrombin‐activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia

J. Meijers, B. Bouma, R. Fijnheer, 2000, British journal of haematology.

Ultraviolet‐B irradiation of platelets induces a dose‐dependent increase in the expression of platelet activation markers with storage

J. Akkerman, H. Weelden, H. C. Prooijen, 1993, British journal of haematology.

Mutation analysis of patients with Hermansky-Pudlak syndrome: a frameshift hot spot in the HPS gene and apparent locus heterogeneity.

R. Spritz, E. Legius, E. Héon, 1998, American journal of human genetics.

Hermansky-Pudlak syndrome is caused by mutations in HPS4, the human homolog of the mouse light-ear gene

Wei Li, R. Spritz, D. Bennett, 2002, Nature Genetics.

storage platelets and present in dense granules, indicating a role in mediator The nucleotide transporter MRP4 (ABCC4) is highly expressed in human

H. Kroemer, A. Greinacher, H. K. Nieuwenhuis, 2013 .

The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage.

H. Kroemer, A. Greinacher, J. Akkerman, 2004, Blood.

Platelet prothrombin converting activity in hereditary disorders of platelet function

H. K. Nieuwenhuis, P. Comfurius, J. Caen, 1986, British journal of haematology.

Large Platelets Circulate in an Activated State in Diabetes Mellitus

F. Gries, D. Tschoepe, J. Esser, 1991, Seminars in thrombosis and hemostasis.

Sebastian platelet syndrome: A new variant of hereditary macrothrombocytopenia with leukocyte inclusions

J. White, A. Greinacher, H. Nieuwenhuis, 1990, Blut.

Elucidation of a novel pathogenomic mechanism using genome-wide long mate-pair sequencing of a congenital t(16;21) in a series of three RUNX1-mutated FPD/AML pedigrees

M. Poot, W. Kloosterman, M. Gijn, 2012, Leukemia.

Soluble P-selectin as Parameter for Platelet Activation during Storage

R. Fijnheer, D. de Korte, R Fijnheer, 1996, Thrombosis and Haemostasis.

Platelet Membrane Activation Markers Are Predictive for Increased Risk of Acute Ischemic Events After PTCA

F. Gries, D. Tschoepe, B. Strauer, 1993, Circulation.

Alpha 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activity.

L. Nelles, C. Kluft, H. K. Nieuwenhuis, 1987, Science.

Congenital deficiencies in α2-antiplasmin

E. Vellenga, C. Kluft, H. Nieuwenhuis, 1984, La Ricerca in clinica e in laboratorio.

Sequential Regulation of the Small GTPase Rap1 in Human Platelets

J. Bos, C. Négrier, J. Akkerman, 2000, Molecular and Cellular Biology.

Platelet activation during hemodialysis measured through exposure of p-selectin: analysis by flow cytometric and ultrastructural techniques.

N. Villamor, G. Escolar, A. Cases, 1994, The Journal of laboratory and clinical medicine.

HK Utrecht: missense mutation in the active site of human hexokinase associated with hexokinase deficiency and severe nonspherocytic hemolytic anemia.

E. Huizinga, W. V. van Solinge, R. van Wijk, 2003, Blood.

Binding of human von Willebrand factor to collagen and to collagen-stimulated platelets.

C. Rothschild, É. Fressinaud, D. Meyer, 1987, The Journal of laboratory and clinical medicine.

Molecular analysis of the genotype-phenotype relationship in factor X deficiency

D. Cooper, M. Krawczak, A. Wacey, 2000, Human Genetics.

PTCA: periprocedural platelet activation. Part II of the Duesseldorf PTCA platelet study (DPPS)

F. Gries, D. Tschoepe, B. Strauer, 1996, European heart journal.

Exposure of Adhesion Molecules on Activated Platelets in Patients with Newly Diagnosed IDDM Is Not Normalized by Near-Normoglycemia

F. Gries, D. Tschoepe, E. Driesch, 1995, Diabetes.

Low-density lipoprotein enhances platelet secretion via integrin-alphaIIbbeta3-mediated signaling.

M. Huigsloot, J. Akkerman, C. Hackeng, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A.

P. D. de Groot, T. Lambert, E. Mauser-Bunschoten, 2002, Blood.

CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells.

M J Metzelaar, H C Clevers, J J Sixma, 1991, The Journal of biological chemistry.

Platelet Adhesion to Collagen

J. Sixma, P. D. de Groot, H. Nieuwenhuis, 1995, Thrombosis and Haemostasis.

Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis.

P. D. de Groot, H. Janssen, F. Leebeek, 2001, Gastroenterology.

Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia

J. Sixma, J. Akkerman, H. Nieuwenhuis, 1985, Nature.

Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux

P. D. de Groot, M. Levi, H. Nieuwenhuis, 2003, Journal of thrombosis and haemostasis : JTH.

Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation.

P. D. de Groot, H. Nieuwenhuis, T. Lisman, 2003, Blood.

Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism.

R. Snijder, F. Verzijlbergen, H. Nieuwenhuis, 2004, The Journal of laboratory and clinical medicine.